{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:26:32Z","timestamp":1780590392181,"version":"3.54.1"},"reference-count":10,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T00:00:00Z","timestamp":1511827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Translational Sci"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1111\/cts.12513","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T17:06:11Z","timestamp":1511975171000},"page":"106-108","source":"Crossref","is-referenced-by-count":4,"title":["Reverse Translation in Advancing Pharmacotherapy in Pediatric Rheumatology: A Logical Approach in Rare Diseases with Limited Resources"],"prefix":"10.1111","volume":"11","author":[{"given":"Mara L.","family":"Becker","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation Children's Mercy Kansas City  Kansas City Missouri USA"},{"name":"Division of Rheumatology Children's Mercy Kansas City  Kansas City Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Funk","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation Children's Mercy Kansas City  Kansas City Missouri USA"},{"name":"Department of Pharmacy Practice University of Kansas Medical Center  Kansas City Kansas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,28]]},"reference":[{"key":"e_1_2_5_1_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090952"},{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340912"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050473"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24601"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30080"},{"key":"e_1_2_5_6_1","first-page":"1573","article-title":"Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis","volume":"20","author":"Ravelli A.","year":"1993","journal-title":"J. Rheumatol."},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203723"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38865"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1938"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12399"}],"container-title":["Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcts.12513","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.12513","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T09:14:38Z","timestamp":1695546878000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1111\/cts.12513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,28]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1111\/cts.12513"],"URL":"https:\/\/doi.org\/10.1111\/cts.12513","archive":["Portico"],"relation":{},"ISSN":["1752-8054","1752-8062"],"issn-type":[{"value":"1752-8054","type":"print"},{"value":"1752-8062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,28]]}}}